IP Library Granted Patent US 10,907,194
Granted Patent B2
US 10,907,194 · App. 14/992,784 · Granted Feb 2, 2021

Synthesis of four-color 3′-O-allyl modified photocleavable fluorescent nucleotides and related methods

Inventors: Jingyue Ju (Englewood Cliffs, NJ); Qinglin Meng (Sunnyvale, CA); Dae H Kim (New York, NY); Lanrong Bi (New York, NY); Xiaopeng Bai (Watertown, MA); Nicholas J Turro (Tenafly, NJ)
Assignee: The Trustees of Columbia University in the City of New York
C12Q1/6806C07H1/04C07H19/067C07H19/10C07H19/14C12Q1/6869C12Q1/6874C12Q2521/101C12Q2525/117C12Q2525/186C12Q2563/107
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,907,194
App. No.
14/992,784
Granted
Feb 2, 2021
Kind
B2
Abstract

This invention provides a process for making 3′-O-allyl-dGTP-PC-Biodopy-FL-510, 3′-O-allyl-dATP-PC-ROX, 3′-O-allyl-dCTP-PC-Bodipy-650 and 3′-O-allyl-dUTP-PC-R6G, and related methods.

Claims (14)

1. A method for determining the sequence of a DNA comprising performing the following steps for each residue of the DNA to be sequenced:

(a) contacting the DNA with a DNA polymerase in the presence of (i) a primer and (ii) four fluorescent nucleotide analogues under conditions permitting the DNA polymerase to catalyze DNA synthesis, wherein (1) the nucleotide analogues consist of an analogue of dGTP, an analogue of dCTP, an analogue of dTTP or dUTP, and an analogue of dATP, (2) each nucleotide analogue comprises (i) a base selected from the group consisting of adenine, guanine, cytosine, thymine, or uracil and analogues thereof, (ii) a deoxyribose, (iii) a fluorophore photocleavably attached to the base, and (iv) an allyl moiety bound to the 3′-oxygen of the deoxyribose, so that a nucleotide analogue complementary to the residue being sequenced is bound to the DNA by the DNA polymerase, and (3) each of the four analogues has a predetermined fluorescence wavelength which is different than the fluorescence wavelengths of the other three analogues;

(b) removing unbound nucleotide analogues;

(c) determining the identity of the bound nucleotide analogues; and

(d) following step (c), except with respect to the final DNA residue to be sequenced, (i) chemically cleaving from the bound nucleotide analogue the allyl moiety bound to the 3′-oxygen atom of the deoxyribose and (ii) photocleaving the fluorophore from the bound nucleotide analogue, wherein steps (d)(i) and (d)(ii) can be performed concurrently or in any order, and step (d)(i) is performed using a Pd catalyst at a pH of about 8.8,

thereby determining the sequence of the DNA.

2. The method of claim 1 , wherein chemically cleaving the allyl moiety bound to the 3′-oxygen atom is performed using Na 2 PdCl 4 .

3. The method of claim 1 , wherein the primer is a self-priming moiety.

4. The method of claim 1 , wherein the DNA is bound to a solid substrate.

5. The method of claim 4 , wherein the DNA is bound to the solid substrate via 1,3-dipolar azide-alkyne cycloaddition chemistry.

6. The method of claim 4 , wherein about 1000 or fewer copies of the DNA are bound to the solid substrate.

7. The method of claim 1 , wherein the four fluorescent nucleotide analogues are 3′-O-allyl-dGTP-PC-Bodipy-FL-510, 3′-O-allyl-dATP-PC-ROX, 3′-O-allyl-dCTP-PC-Bodipy-650 and 3′-O-allyl-dUTP-PC-R6G.

8. The method of claim 1 , wherein the DNA polymerase is a 9° N polymerase.

9. The method of claim 1 , wherein in step d) (ii) the fluorophore is photocleaved under near UV radiation (λ˜355 nm).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 23, 2020
From: JU, JINGYUE; MENG, QINGLIN; KIM, DAE H.; BI, LANRONG; BAI, XIAOPENG; TURRO, NICHOLAS J.
To: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
Reel/Frame 053854/0855 →
CONFIRMATORY LICENSE Recorded Jun 27, 2016
From: COLUMBIA UNIV NEW YORK MORNINGSIDE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039172/0938 →
Continuity (4)
Continuation 13186353 · Jul 19, 2011
Continuation 12084338
Provisional Application 60732373 · Oct 31, 2005
Related Publication 20160208313A1 · Jul 21, 2016